Mounjaro

• Many regain weight after stopping GLP-1 drugs, data shows. Here’s why

  People on average regain weight at a rate of 0.4 kg/month after they stopped taking their weight loss medications, a review of 63 trials covering over 9,000 individuals showed.

  Health

  Jan 8
  
• Canadians won’t see price of weight-loss drug Mounjaro rise despite U.K. hike

  Pharmaceutical giant Eli Lilly said last week that it will raise the U.K. list price of its weight-loss treatment Mounjaro by up to 170 per cent.

  Canada

  Aug 20, 2025
  
• Advertisement
• Eli Lilly’s weight-loss drug cuts diabetes risk, long-term study finds

  The three-year study of tirzepatide found adults with prediabetes and obesity or overweight taking the drug weekly saw the risk of progression to diabetes lower by 94 per cent.

  Health

  Aug 20, 2024
• Advertisement
• Eli Lilly’s new version of diabetes drug Mounjaro approved for weight loss by FDA

  A new version of the popular diabetes treatment Mounjaro from Eli Lilly can be sold as a weight-loss drug, U.S. regulators announced Wednesday.

  Health

  Nov 8, 2023
• Alternative drug now available as Ozempic shortage looms

  Novo Nordisk, the company that makes Ozempic, has been warning doctors that the drug will be difficult to get as the new year looms.

  Health

  Nov 3, 2023
• ‘Nature’s Ozempic’ a ‘scam’ — but these 3 obesity drugs are seeing stunning results

  Doctors are getting excited about new hormonal treatments for obesity that may even be more effective than Ozempic, according to early-stage clinical trials.

  Lifestyle

  Sep 4, 2023
• Move over Ozempic — even more powerful weight-loss drug is in the works

  Industry analysts predict that tirzepatide could become one of the top-selling drugs ever, with annual sales topping US$50 billion.

  Health

  Apr 27, 2023